Brief: Medicenna Therapeutics Received Conditional Approval To Extend Expiry Date Of Warrants

Medicenna Therapeutics

30/09/2022 12:08

Sept 30 (Reuters) - 
  
    * MEDICENNA THERAPEUTICS CORP - CO RECEIVED CONDITIONAL
APPROVAL
FROM TORONTO STOCK EXCHANGE TO EXTEND EXPIRY DATE OF WARRANTS
ORIGINALLY ISSUED OCT 17
    * MEDICENNA THERAPEUTICS CORP - CO EXTENDED EXPIRY DATE OF
SUCH
WARRANTS TO JULY 17, 2023, WITH EXTENSION BEING EFFECTIVE ON
OCTOBER 17
    * MEDICENNA THERAPEUTICS CORP - ALL OTHER TERMS OF WARRANTS,
INCLUDING EXERCISE PRICE, REMAIN UNCHANGED

Source text for Eikon:  ID:nGNXb4KHdf 
Further company coverage: [ ]
 ((Reuters.Briefs@thomsonreuters.com;))